Cancer Diagnostic Testing: Granular Analysis of the Global Market Supplier Shares and Forecasts for Current and Emerging Tumor Markers France, Germany, Italy, Japan, Spain, UK, US

Date: June 20, 2013
Pages: 450
Price:
US$ 21,100.00 US$ 17,935.00
License [?]:
Publisher: VPGMarketResearch.com
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: CD4E632410CEN
Leaflet:

Download PDF Leaflet

Cancer Diagnostic Testing: Granular Analysis of the Global Market Supplier Shares and Forecasts for Current and Emerging Tumor Markers France, Germany, Italy, Japan, Spain, UK, US
This DataPack contain 450 tables from Venture Planning Group new 7-country study, “Competing in the Global Cancer Diagnostics Market,” including supplier shares, as well as test volume and sales forecasts for 40 tumor markers. The DataPack will help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global cancer diagnostics market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies.

Geographic Coverage
  • France
  • Germany
  • Italy
  • Japan
  • Spain
  • UK
  • USA
Market Segmentation Analysis
  • Sales and market shares of major suppliers, by individual tumor marker and country.
Five-year test volume and sales forecasts for major tumor markers by country and market segment, including:
  • Hospitals
  • Commercial/Private Laboratories
  • Physician Offices/Group Practices
  • Cancer Clinics
Worldwide Market Overview
  • Estimated universe of laboratories performing tumor marker testing by country.
  • Five-year test volume and sales projections by country.
Contains 450 tables
LIST OF TABLES

Tumor Marker Classification
Major Companies Developing or Marketing ACTH Tests
Major Companies Developing or Marketing AFP Tests
Major Companies Developing or Marketing Beta-2 Microglobulin Tests
Major Companies Developing or Marketing CA 15-3/27.29 Tests
Major Companies Developing or Marketing CA 19-9 Tests
Major Companies Developing or Marketing CA 125 Tests
Major Companies Developing or Marketing Calcitonin Tests
Major Companies Developing or Marketing CEA Tests
Major Companies Developing or Marketing Estrogen Receptor Tests
Major Companies Developing or Marketing Progesterone Receptor Tests
Major Companies Developing or Marketing Ferritin Tests
Major Companies Developing or Marketing Gastrin Tests
Major Companies Developing or Marketing HCG Tests
Major Companies Developing or Marketing Insulin Tests
Major Companies Developing or Marketing NSE Tests
Major Companies Developing or Marketing Occult Blood Tests
Major Companies Developing or Marketing PAP Smear/HPV Tests
Major Companies Developing or Marketing PAP Tests
Major Companies Developing or Marketing PSA Tests
Major Companies Developing or Marketing Lymphocyte Subclassification Tests
Biochemical Markers Potential Applications In Cancer Diagnosis
Oncogenes Potential Applications In Cancer Diagnosis
Major Companies Developing or Marketing Oncogene Tests
Growth Factors Potential Applications In Cancer Diagnosis
Colony Stimulating Factors Potential
Applications in Cancer Diagnosis
Lymphokines Potential Applications In Cancer Diagnosis

Ask Your Question

Cancer Diagnostic Testing: Granular Analysis of the Global Market Supplier Shares and Forecasts for Current and Emerging Tumor Markers France, Germany, Italy, Japan, Spain, UK, US
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: